key: cord-1003243-jlwy02d2
authors: Kates, Olivia S.; Fisher, Cynthia E.; Rakita, Robert M.; Reyes, Jorge D.; Limaye, Ajit P.
title: Emerging evidence to support not always “just saying no” to SARS‐CoV‐2 positive donors
date: 2020-06-18
journal: Am J Transplant
DOI: 10.1111/ajt.16119
sha: 14c0e1d5fb7c238248604d4a52747e819ab92b12
doc_id: 1003243
cord_uid: jlwy02d2

We are gratified to see the broad discussion of our manuscript, "Use of SARS-CoV-2 infected deceased organ donors: Should we always 'just say no?'" and the companion manuscript by Shah et al., "Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors."1,2 Our viewpoint argues that the risk of SARS-CoV-2 transmission from asymptomatic or minimally symptomatic donors is likely very low. For selected patients with imminently life-threatening organ failure, transplants from deceased donors with asymptomatic or mild SARS-CoV-2 infection may offer a favorable risk/benefit balance, although factors beyond transmission risk must also be considered.

To the Editor,

We are gratified to see the broad discussion of our manuscript, "Use hope that discussion of this important topic and serious consideration of the accumulating evidence will continue. We encourage providers to share their experience with the use (intended or unintended) of organs from SARS-CoV-2 infected donors, so

Use of SARS-CoV-2 infected deceased organ donors: should we always "just say no?

Utilization of deceased donors during a pandemic: an argument against using SARS-CoV-2 positive donors

COVID-19 transmission and blood transfusion: a case report

A case of coronavirus disease 2019-infected liver transplant donor